The second exosome company has now listed on the US stock exchange and has a $222m AUD market cap - I believe they are at a similar stage to Exopharm. It was actually closer to $500m aud market cap when they listed last month. I am looking forward to the share price appreciation that we will hopefully see in the coming six months to put us into the few hundred million dollar range and will likely continue to add to my holding on dips. We are at the forefront of this exciting new biotech and I won't be selling.
- Forums
- ASX - By Stock
- TYP
- Codiak Biosciences ($200m market cap)
Codiak Biosciences ($200m market cap)
-
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
Add TYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.001(5.00%) |
Mkt cap ! $22.87M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 2.0¢ | $6.632K | 320.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 446080 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 29839 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 446080 | 0.020 |
3 | 590980 | 0.019 |
4 | 656509 | 0.018 |
2 | 305000 | 0.017 |
3 | 2240000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 29839 | 1 |
0.022 | 125000 | 1 |
0.023 | 277236 | 2 |
0.024 | 590529 | 3 |
0.025 | 200000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |